A23V 2250/0648
Threonine
A23V2250/0648 (Threonine) appears on 5 US grants and 6 published applications in this corpus.
Search patents in A23V- Granted patents
- 5
- Published applications
- 6
- Assignees
- 6
- Inventors
- 16
- Latest grant
- 9 May 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 2 |
| 2020 | 1 | 1 |
| 2021 | 1 | 1 |
| 2022 | 1 | 0 |
| 2023 | 1 | 1 |
By publication year.
Recent patents
- Prevention or remediation composition for dementia or depression9 May 2023US 11,642,326 B2Ajinomoto Co., Inc.
- Composition to improve athletic performance by supporting muscle protein synthesis and mental focus16 Aug 2022US 11,412,771 B2Amino Corporation
- Prevention or remediation composition for dementia or depression18 May 2021US 11,007,164 B2Ajinomoto Co., Inc.
- Composition containing amino acids and process for producing same24 Nov 2020US 10,842,164 B2Wolfgang Priemer
- Nutritional composition useful in the treatment of IBD patients27 Nov 2018US 10,137,108 B2Nestec S. A.
- Metabolic therapy of cancer19 Oct 2023US 2023/0329304 A1Aminovita S.L.
- Prevention or remediation composition for dementia or depression1 Apr 2021US 2021/0093601 A1Ajinomoto Co., Inc.
- Composition to improve athletic performance by supporting muscle protein synthesis and mental focus15 Oct 2020US 2020/0323251 A1Amino Corporation
- Prevention or remediation composition for dementia or depression15 Aug 2019US 2019/0247347 A1Ajinomoto Co., Inc.
- Composition containing amino acids31 Jan 2019US 2019/0029280 A1Wolfgang Priemer
Most cited
By later US patents